zum Inhalt

Dr. Gerald CHAN Co-Founder, Morningside Group; Director, The Morningside Foundation, Shanghai

CV

1972 B.Sc., M.Sc. in Engineering, University of California, Los Angeles
1975 Master of Science in Medical Radiological Physics, Harvard University, Cambridge, Massachusetts
1979 Doctor of Science in Radiation Biology, Harvard University, Cambridge, Massachusetts
1979-1980 Postdoctoral Fellow in Radiobiology, Harvard School of Public Health
1980-1984 Research Fellow in Pathology, Harvard Medical School and Dana-Farber Cancer Institute
1984-1985 Private Investor
 Company Directorship:
1986 Co-founder and Director, The Morningside Group Limited
since 1986 Hang Lung Group Limited, one of the largest China-focused real estate companies listed on the Hong Kong Stock Exchange
since 1993 Morningside (China) Company Ltd., an investment management company which manages a portfolio of operating companies in mainland China in diverse industries including paper, building materials, machinery, media, communication, biotechnology and health care
since 1996 Natural Polymer International Corporation, Richardson, Texas, a technology company which develops and manufactures biodegradable plastic substitute materials
since 1996 The Morningside Foundation
since 2002 Morningside (HBR) Limited, Publisher of the Harvard Business Review, Chinese edition
since 2002 Bright Wealth Resources Limited, Publisher of Forbes magazine, Chinese edition
  Vaccine Technologies Inc, Boston, Massachusetts and Haikou, China, developer of a Hepatitis B vaccine using a novel route of antigen presentation
since 2004 Serica Technologies, Medford, Massachusetts, a clinical development stage biotech company with a technology for soft tissue regeneration
since 2005 Metacure, Inc, Israel and New York based company, maker of an implantable device which uses electrical signals to reduce appetite for food as treatment for obesity and diabetes
since 2006 Critical Biologics Corporation, Cambridge, Massachusetts, a biotech company developing diagnostics and a biologic therapeutic for sepsis and end-stage renal disease
since 2007 Stealth Peptide Inc., a biotech company developing a series of small peptides which protect the mitochondria from oxidative stress
since 2007 Matrivax, a biotech company based in Boston, Massachusetts and Haikou, China, with novel technology for making multivalent polysaccharide vaccines
since 2008 Inimex Pharmaceuticals, Vancouver, Canada, developing first-in-class drugs for infectious diseases and cancer that work by triggering the body s innate immune system without causing inflammation

Mitgliedschaften

Council on Foreign Relations, New York, NY, since 1995
Physical Sciences Visiting Committee, College of Letters and Science, University of California, Los Angeles, since 2002
Madam Sun Yat San Foundation, Shanghai, China, Trustee, since 2004
The Johns Hopkins University - Nanjing University Center for Chinese and American Studies, Advisory Council, since 2004
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, President's Council, since 2004
Fudan University, Shanghai, China, Trustee, since 2006
Harvard China Advisory Group, Cambridge, Massachusetts, since 2008